The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
tocilizumab · Liquid
7 marketed package NDCs · 6 active manufacturers
Most dispensed: 162 mg/.9mL · Injection, Solution · #1 syringe, glass/box / .9 ml in 1 syringe, glass
What changed in the last 90 days
Every detected change for tocilizumab, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Tocilizumab-anohAug 5, 2026Mfr exitedCELLTRION USA, Inc. · tocilizumab
- Tocilizumab-anohAug 5, 2026Mfr exitedCELLTRION USA, Inc. · tocilizumab
- Tocilizumab-anohAug 5, 2026Mfr exitedCELLTRION USA, Inc. · tocilizumab
Same drug class
Other molecules FDA puts in Interleukin-6 Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Tocilizumab in shortage right now?
- No. FDA does not currently list Tocilizumab in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Tocilizumab?
- 9 companies have marketed Tocilizumab in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Tocilizumab cost?
- The typical pharmacy pays about $1,279.06 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.